Navigation Links
Amylin Pharmaceuticals Reports 2007 Financial Results
Date:1/28/2008

nd enhance the profile of exenatide once weekly, the advancement of our obesity program, and continued investments in discovery research."

Quarter ended December 31, 2007

Net product sales of $194.7 million for the quarter include sales of $176.3 million for BYETTA(R) (exenatide) injection and $18.4 million for SYMLIN(R) (pramlintide acetate) injection. This compares to net product sales of $150.6 million, consisting of $137.0 million for BYETTA and $13.6 million for SYMLIN for the same period in 2006.

Revenue under collaborative agreements was $27.3 million for the quarter ended December 31, 2007, compared to $12.8 million for the same period in 2006. The increase reflects higher cost-sharing payments from Lilly and Company to equalize development expenses for BYETTA and exenatide once weekly.

The Company's results for quarter ended December 31, 2007 includes $17 million in full year non-cash expense associated with the adoption of an ESOP of which $10 million is included in selling, general and administrative expenses and $7 million is included in research and development expenses. The adoption of the ESOP represents a change in the composition of the Company's equity compensation.

Selling, general and administrative expenses increased to $122.4 million for the quarter ended December 31, 2007, compared to $89.6 million for the same period in 2006. The increase primarily reflects increased promotional expenses for BYETTA and SYMLIN and increased business infrastructure to support the Company's growth.

Research and development expenses increased to $83.9 million for the quarter ended December 31, 2007, compared to $66.2 million for the same period in 2006. The increase primarily reflects costs associated with the development of exenatide once weekly, including manufacturing scale-up.

Collaborative profit sharing, which represents Lilly's share of the gross margin for BYETTA, was $78.6 million for the quarter ended Dec
'/>"/>

SOURCE Amylin Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine news :

1. Xenome Enters Into Joint Research Collaboration to Discover Novel Peptide Therapeutics with Amylin Pharmaceuticals
2. Amylin Pharmaceuticals to Present at Research & Development Day
3. Amylin Pharmaceuticals to Webcast Conference Call
4. Amylin Pharmaceuticals to Webcast Third Quarter Results
5. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
6. MiddleBrook Pharmaceuticals to Raise $21 Million Through Private Placement of Common Equity
7. Acura Pharmaceuticals, Inc. Announces Appointment of George K. Ross as Director
8. Wyeth and Teva Pharmaceuticals Extend the Standstill Period Relating to Tevas Launch of Generic Pantoprazole
9. Bradley Pharmaceuticals Announces Filing of Definitive Proxy Statement for Special Meeting of Stockholders to Approve Merger With Nycomed
10. MAP Pharmaceuticals Reaches Agreement with FDA on Special Protocol Assessment for MAP0004 Phase 3 Clinical Trial in Patients With Migraine
11. Access Licenses MuGard(TM) to RHEI Pharmaceuticals, a Leading Specialty Pharmaceutical Company for Distribution in China and Certain Other Southeast Asian Countries
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... Scottsdale, AZ (PRWEB) , ... ... ... Services, Inc. (EMSI), a leading provider of medical information, risk management and ... the company’s evolution and direction toward focused, expert information solutions that improve ...
(Date:8/3/2015)... ... August 03, 2015 , ... Did you know that there ... looking for exceptional and affordable home care options which A-1 Home Care Agency specialize ... few of the credentials A-1 Home Care Agency is known for. ...
(Date:8/2/2015)... ... August 03, 2015 , ... Career Step, ... exhibiting at the Association for Healthcare Documentation Integrity’s (AHDI) conference being held in ... for the opportunity the AHDI conference provides us to interact with those in ...
(Date:8/2/2015)... ... August 03, 2015 , ... For many “would be” entrepreneurs, starting a new business ... “I can’t afford to start a business.” Neither needs be a major obstacle. , ... opportunity to start a business and be successful. The risks of starting a business can ...
(Date:8/2/2015)... ... August 02, 2015 , ... Molecular biologists in New South ... for mesothelioma. Surviving Mesothelioma has just posted an article on the new research. ... South Wales tested for Ki67 expression in tissue samples from 42 patients with peritoneal ...
Breaking Medicine News(10 mins):Health News:EMSI Announces New Branding: Powerful Information. Improved Outcomes. 2Health News:A-1 Home Care in Los Angeles and Orange County Honors Exceptional Office Staff 2Health News:A-1 Home Care in Los Angeles and Orange County Honors Exceptional Office Staff 3Health News:Career Step to Exhibit at AHDI Conference in Alexandria, Virginia on August 7-8 2Health News:Newport Board Group, an Advisory Firm Serving Middle Market Companies, Releases a 5 Step Guide to Starting a Successful Business for Under $1,000 2Health News:Newport Board Group, an Advisory Firm Serving Middle Market Companies, Releases a 5 Step Guide to Starting a Successful Business for Under $1,000 3Health News:Newport Board Group, an Advisory Firm Serving Middle Market Companies, Releases a 5 Step Guide to Starting a Successful Business for Under $1,000 4Health News:Newport Board Group, an Advisory Firm Serving Middle Market Companies, Releases a 5 Step Guide to Starting a Successful Business for Under $1,000 5Health News:Scientists Link Protein Marker with Mesothelioma Prognosis in New Study, According to Surviving Mesothelioma 2
... Sutter Spokesperson Admits Less Charity Care Required in Favored, Neighborhoods - New ... ... Luke,s, OAKLAND, Calif., Jan. 30 Sutter Health ... North of,Market CPMC campuses offer dramatically less charity care than St. Luke,s,Hospital, ...
... Inc. announced last week the acquisition of Mediplete, ... and southern California., (Logo: http://www.newscom.com/cgi-bin/prnh/20080130/AQW173 ), ... comes at the confluence of,two goals: for Mediplete, ... board for their clients in an IT-savvy environment, ...
... 30, 2008 In the years following the government ... reached almost epidemic levels. Were the federal guidelines a ... a well-meaning but unimportant factor" In a study published ... of Preventive Medicine, Paul R Marantz, MD, MPH, Elizabeth ...
... Authors of 1996 study that concluded differently took second ... (HealthDay News) -- A woman,s personality traits do not ... , In 1996, researchers at The Netherlands Cancer Institute ... and anti-emotionality, a lack of emotional behavior or trust ...
... 2008 Projected Financial Highlights and Potential Milestones include:, ... Marketing Authorization Application submission in Q1, - ... - Brostallicin phase II interim results ... MTAX: CTIC) announced today that with the return of ...
... 15,204 Square Foot Lease at Class-A Office Tower, ... one of the,largest development companies in the New ... relocate its U.S. headquarters,to Waterfront Corporate Center II, ... the Northeast. Octapharma, an independent, global plasma,fraction specialist, ...
Cached Medicine News:Health News:Government dietary guidelines, unintended consequences and public policy 2Health News:Government dietary guidelines, unintended consequences and public policy 3Health News:Personality Traits Don't Affect Breast Cancer Risk 2Health News:Cell Therapeutics, Inc. (CTI) Cuts Net Operating Expenses 35% and Expands Commercial Team to Support Zevalin(R) Sales and Applications Seeking Two Product Approvals in 2009 2Health News:Cell Therapeutics, Inc. (CTI) Cuts Net Operating Expenses 35% and Expands Commercial Team to Support Zevalin(R) Sales and Applications Seeking Two Product Approvals in 2009 3Health News:Cell Therapeutics, Inc. (CTI) Cuts Net Operating Expenses 35% and Expands Commercial Team to Support Zevalin(R) Sales and Applications Seeking Two Product Approvals in 2009 4Health News:Cell Therapeutics, Inc. (CTI) Cuts Net Operating Expenses 35% and Expands Commercial Team to Support Zevalin(R) Sales and Applications Seeking Two Product Approvals in 2009 5Health News:First Pharmaceutical Company Comes to Hoboken, NJ: Swiss-Based Octapharma to Move U.S. Headquarters to SJP Properties Waterfront Corporate Center II 2Health News:First Pharmaceutical Company Comes to Hoboken, NJ: Swiss-Based Octapharma to Move U.S. Headquarters to SJP Properties Waterfront Corporate Center II 3Health News:First Pharmaceutical Company Comes to Hoboken, NJ: Swiss-Based Octapharma to Move U.S. Headquarters to SJP Properties Waterfront Corporate Center II 4
(Date:8/3/2015)... , August 3, 2015 ... FN Media Group LLC, PIV757417 The following release: ... Developing Orphan Drug Products & Treatments for Critical-Care ... HOLD. Distribution time: 3 Aug 2015 12:30 GMT ... biotech companies, military surgical research and top-tier universities ...
(Date:8/3/2015)... N.J. , Aug. 3, 2015  Celsion ... the Company will host a conference call to ... provide an update on its development programs for ... and two newly acquired technology platforms, TheraPlas™ and ... a.m. EDT on Monday, August 10, 2015. To ...
(Date:8/3/2015)... , Aug. 3, 2015  EnteroMedics Inc. (NASDAQ: ETRM ... to treat obesity, metabolic diseases and other gastrointestinal disorders, ... been appointed to the Board of Directors, effective July ... II Director until the 2018 annual meeting or until ... McDougal has served in an executive capacity in the ...
Breaking Medicine Technology:/OFF HOLD OFF HOLD OFF HOLD -- FN Media Group LLC/ 2/OFF HOLD OFF HOLD OFF HOLD -- FN Media Group LLC/ 3/OFF HOLD OFF HOLD OFF HOLD -- FN Media Group LLC/ 4/OFF HOLD OFF HOLD OFF HOLD -- FN Media Group LLC/ 5/OFF HOLD OFF HOLD OFF HOLD -- FN Media Group LLC/ 6Celsion Corporation to Hold Second Quarter 2015 Financial Results Conference Call on Monday, August 10, 2015 2EnteroMedics Announces Appointment of Lori C. McDougal to the Board of Directors 2EnteroMedics Announces Appointment of Lori C. McDougal to the Board of Directors 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: